Change is clearly a common occurrence in the laboratory environment, but what can happen to our profession when other influencing factors come in to play?
In the case of cytology, these (among other things) are seen in the form of increased slide limits brought about by image-guided screening, molecular testing for HPV and decreased Pap test frequency.
Market dynamics is a fundamental concept governing supply, demand and the consequential cost of a certain product or service.
When looking at market dynamics, pricing signals are generated as a result of changes in either the supply or demand for a specific service that forces a corresponding change in the other.
With this in mind, if the supply and demand (and pricing factors) concerning cytology services are beyond our control, the strategy has to be one that is adaptive in nature, stemming from within the profession.
Cytology can definitely change, and the greater question lingers, should we change? And if so, how? Although gyn cytology work volumes may be expected to decrease, anticipated workforce cannot be based mainly on the Pap test.
Non-gyn cytology and fine needle aspiratoins are not affected by these current changes, thus workload in that area should remain the same, and even increase.
Learn how cytology professionals are adapting to change in the face of new technologies, regulations and supply and demand in this compilation of our best cytology features:
- Beyond the Microscope
- CLIA '88 to Present
- Market Dynamics